Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Acute hypoxemic respiratory failure

Acute hypoxemic respiratory failure

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Acute hypoxemic respiratory failure

4 trials tracked for Acute hypoxemic respiratory failure.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2 Other / NA 2
  1. Phase 2 Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old Completed
  2. Phase 2 Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 Completed
  3. N/A Strategies for Anticoagulation During Venovenous ECMO Completed
  4. N/A Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Multicomponent telehealth-based rehabilitation improves quality of life and reduces mortality in acute hypoxemic respiratory failure
Emergency Medicine RCT
Multicomponent telehealth-based rehabilitation improves quality of life and reduces mortality in acute hypoxemic respiratory failure Telehealth rehabilitation program improves outcomes for patients with respiratory failure
This randomized clinical trial of 1,916 adults with acute hypoxemic respiratory failure requiring invasive mechanical ventilation found that…
A new telehealth program helps patients with severe respiratory failure stay on ventilators for fewer days and improves survival rates.
JAMA Sep 16, 2026